Companies In the News
Authors:
Date:
Business Wire: August 14, 2017 – NEW YORK, NY, U.S.A. – PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced financial results for the three and six months ended June 30, 2017, and provided a business update.
“During this past quarter and…
Date:
Business Wire: August 7, 2017 – JERUSALEM, Israel – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved QVAR® RediHaler™ (beclomethasone dipropionate HFA) inhalation aerosol, a breath-actuated inhaler for the…
Authors:
Date:
PRNewswire: July 31, 2017 – DUBLIN, Ireland – Perrigo Company plc (NYSE; TASE: PRGO) and its co-development partner Aveva Drug Delivery Systems, Inc., an Apotex Company, today announced the prescription pharmaceutical launch of scopolamine 1.5 mg transdermal system patch, the AB rated generic…
Authors:
Date:
Business Wire: July 27, 2017 – HAYWARD, CA, U.S.A. – Aradigm Corporation (NASDAQ: ARDM) (the “company”) today announced it has submitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Linhaliq™ for the treatment of non-cystic fibrosis bronchiectasis (NCFBE)…
Authors:
Date:
Business Wire: July 26, 2017 – NEW YORK, NY, U.S.A. – Ophthotech Corporation (Nasdaq: OPHT) today announced that the company is pursuing a strategy to leverage its clinical experience and retina expertise to identify and develop therapies to treat multiple orphan ophthalmic diseases for which there…
Authors:
Date:
PRNewswire: July 26, 2017 – KARLSRUHE, Germany – To meet growing demand for innovative drug delivery systems in the pharmaceutical industry, drug formulation scientists can now use the first commercially available, fully integrated solution for polymerbased drug implant development and production…
